Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/20485372

Download in:

View as

General Info

PMID
20485372